SESSION TITLE: Cardiovascular Disease
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Dabigatran and rivaroxaban, commonly used novel anticoagulants, are used as alternatives to warfarin for stroke prevention in patients with atrial arrhythmias. Evidence suggests that the use of dabigatran in patients with renal impairment may increase exposure to active medication. The risk of bleeding complications in these patients particularly in atrial ablation procedures in unknown.